RIPK4 and neoplasm: In contrast, mice overexpressing RIPK4 in the epidermis do not show increased tumor formation when treated with DMBA/PMA [113], supporting the idea that in keratinocytes RIPK4 acts as a tumor suppressor rather than as a tumor promotor.